Pfizer Pays $34.7M To Settle Genotropin Charges
Pfizer Inc. has agreed to pay fines of $34.7 million to settle allegations two subsidiaries engaged in illegal off-label marketing and paid kickbacks to a vendor to boost sales of human...To view the full article, register now.
Already a subscriber? Click here to view full article